NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLCGilberto de Castro, Tony Mok, Ying Cheng et al.|Journal of Thoracic Oncology|2022Cited by 72
The Autotaxin—Lysophosphatidic Acid Axis Promotes Lung CarcinogenesisChristiana Magkrioti, Vassilis Aidinis, Nikos Oikonomou et al.|Cancer Research|2018Cited by 62
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancerThazin Nwe Aung, David L. Rimm, James Monkman et al.|Nature Genetics|2025Cited by 33